| Autor: |
Ismail RK; Dutch Institute for Clinical Auditing, Leiden, the Netherlands. r.ismail@dica.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. r.ismail@dica.nl.; Medicines Evaluation Board, Utrecht, The Netherlands. r.ismail@dica.nl., Schramel FMNH; Department of Pulmonary Diseases, St Antonius Hospital, Nieuwegein, The Netherlands., van Dartel M; Medicines Evaluation Board, Utrecht, The Netherlands., Pasmooij AMG; Medicines Evaluation Board, Utrecht, The Netherlands., der Welle CMC; Santeon Hospital Group, Utrecht, The Netherlands., Hilarius DL; Department of Clinical Pharmacy, Rode Kruis Hospital, Beverwijk, The Netherlands., de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., van de Garde EMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, Utrecht, The Netherlands. |
